Literature DB >> 8797970

Primary tumour staging of gastric and colorectal cancer.

J N Bruneton1, E Francois, B Padovani, C Raffaelli.   

Abstract

Almost 15 years after its introduction, endosonography or endoscopic ultrasonography is an important technique in a wide range of gastrointestinal diseases. Other imaging techniques are CT, MRI and barium examination. There is a general consensus that the most important prognostic factor in gastric and colorectal carcinoma is the presence or absence of lymph node invasion, but malignant fixation of tumour through direct invasion of adjacent tissues also appears to be very important. Non-invasive preoperative assessment of tumour stage based on one or a combination of the above imaging modalities should allow appropriate treatment to be planned in each case.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8797970     DOI: 10.1007/bf00181129

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  42 in total

1.  Computed tomographic evaluation and staging of cecal carcinoma.

Authors:  G Keeney; S Z Jafri; D G Mezwa
Journal:  Gastrointest Radiol       Date:  1989

Review 2.  Staging of colorectal cancer.

Authors:  S Mehta; R J Johnson; P F Schofield
Journal:  Clin Radiol       Date:  1994-08       Impact factor: 2.350

Review 3.  Colorectal cancer: cross-sectional imaging for staging of primary tumor and detection of local recurrence.

Authors:  R F Thoeni
Journal:  AJR Am J Roentgenol       Date:  1991-05       Impact factor: 3.959

Review 4.  The Japanese experience with endoscopic ultrasonography in the staging of gastric cancer.

Authors:  S Abe; C J Lightdale; M F Brennan
Journal:  Gastrointest Endosc       Date:  1993 Jul-Aug       Impact factor: 9.427

5.  Scirrhous carcinoma of the stomach versus hypertrophic gastritis: findings at endoscopic US.

Authors:  H Fujishima; T Misawa; Y Chijiwa; A Maruoka; K Akahoshi; H Nawata
Journal:  Radiology       Date:  1991-10       Impact factor: 11.105

6.  Impact of endoscopic ultrasonography on diagnosis and treatment of primary gastric lymphoma.

Authors:  G C Caletti; Z Lorena; L Bolondi; G Guizzardi; E Brocchi; L Barbara
Journal:  Surgery       Date:  1988-03       Impact factor: 3.982

7.  Transrectal ultrasound and computed tomography in preoperative staging of lower rectal adenocarcinoma.

Authors:  S Goldman; H Arvidsson; U Norming; U Lagerstedt; I Magnusson; J Frisell
Journal:  Gastrointest Radiol       Date:  1991

8.  Role of endosonography in the surgical management of non-Hodgkin's lymphoma of the stomach.

Authors:  G Schüder; U Hildebrandt; D Kreissler-Haag; G Seitz; G Feifel
Journal:  Endoscopy       Date:  1993-10       Impact factor: 10.093

9.  Endoscopic ultrasound and endorectal magnetic resonance imaging: a prospective, comparative study for preoperative staging and follow-up of rectal cancer.

Authors:  C Meyenberger; R A Huch Böni; P Bertschinger; G F Zala; H P Klotz; G P Krestin
Journal:  Endoscopy       Date:  1995-09       Impact factor: 10.093

10.  Staging of rectal carcinoma: prospective comparison of endorectal US and CT.

Authors:  M D Rifkin; S M Ehrlich; G Marks
Journal:  Radiology       Date:  1989-02       Impact factor: 11.105

View more
  3 in total

1.  Clinical value of magnetic resonance imaging in preoperative T staging of gastric cancer and postoperative pathological diagnosis.

Authors:  Xianying Huo; Kuangsheng Yuan; Yuexia Shen; Min Li; Qi Wang; Lingxiao Xing; Gaofeng Shi
Journal:  Oncol Lett       Date:  2014-05-12       Impact factor: 2.967

2.  CT/MRI accuracy in detecting and determining preoperative stage of gastric adenocarcinoma in Albania.

Authors:  Altin Malaj; Fatmir Bilaj; Albana Shahini; Marjeta Miraka
Journal:  Contemp Oncol (Pozn)       Date:  2017-06-30

Review 3.  Gastric Cancer: Epidemiology, Risk Factors, Classification, Genomic Characteristics and Treatment Strategies.

Authors:  Julita Machlowska; Jacek Baj; Monika Sitarz; Ryszard Maciejewski; Robert Sitarz
Journal:  Int J Mol Sci       Date:  2020-06-04       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.